Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PhRMA Embraces Teva Across Brand-Generic Divide

Jul 15 2016

• By Brenda Sandburg

Related Content

Teva Extends Diversification To Lobbying, Not Just Product Mix; Seeks To Join BIO

Feb 14 2011

Teva Resigning From GPhA: Diversification, Size Led Firm's Priorities In Different Direction

Apr 22 2010

Biosimilars Forum: How Do You Create A Brand-Generic Coalition? Don’t Talk About Naming

May 11 2015

Teva, Allergan Probably Won't Need More Divestments To Get FTC Approval

Jul 13 2016

For Generics Industry, Will Larger Firms Mean Weaker Lobbying?

Mar 21 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Alexion Pharmaceuticals Inc.

Jazz Pharmaceuticals plc

Novartis AG

Novartis AG

Pfizer Inc.

Allergan plc

Allergan plc

Teva Pharmaceutical Industries Ltd.

Hospira, Inc.

AbbVie Inc.

Additional Topics

United States Policy Legislation BioPharmaceutical

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window